Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash flows from operating activities:
Net income (loss)	$ 1,676,012	$ (642,905)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and other amortization	256,237	264,834
Gain on change in fair value of warrant liability	(400,663)	(1,361,070)
Stock-based compensation	764,208	713,817
Write down of inventory, net	157,740	630,707
Deferred income taxes, net	(617,207)	(187,420)
Changes in assets and liabilities:
Accounts receivable	64,052,328	(3,865,872)
Inventory	2,921,257	34,921
Prepaid expenses and other assets	(592,168)	622,109
Accounts payable, accrued expenses and other liabilities	1,582,679	(1,927,150)
Income tax payable	(18,572,423)	(892,148)
Deferred revenue	3,270,658	373,593
Net cash provided by/(used in) operating activities	54,498,658	(6,236,584)
Cash flows from investing activities:
Capital expenditures	0	(24,424)
Cash used in investing activities	0	(24,424)
Cash flows from financing activities:
Payment of employee tax obligations for common stock tendered	(12,533)	(13,361)
Repurchase of common stock	(10,149,704)	(13,129,858)
Payment of dividend	(32,944,314)	0
Cash used in financing activities	(43,106,551)	(13,143,219)
Net increase/(decrease) in cash, cash equivalents and restricted cash	11,392,107	(19,404,227)
Cash, cash equivalents and restricted cash at the beginning of period	103,138,819	117,890,240
Cash and cash equivalents at end of period	114,530,926	98,486,013
Supplemental disclosure of non-cash financing activities:
Conversion of warrant to common stock	$ 6,120,778	$ 0